Institutional Ownership 4 D Molecular Therapeutics, Inc. (FDMT)
This table provides information about the institutional ownership of 4 D Molecular Therapeutics, Inc. (FDMT). We have compiled data on the 124 institutions that hold shares in the stock, with a total of 41.2 Million shares, which have been reported (via 13F filing form) to have a value of $287 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Decheng Capital LLC
Menlo Park, CA |
Aug 13, 2025 Q2 2025 |
239,510
shares
|
$1.66 Million
0.22% of portfolio
|
Q2 2025
Reduced 28.61%
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Aug 12, 2025 Q2 2025 |
226,939
shares
|
$1.57 Million
0.0% of portfolio
|
Q2 2025
Reduced 3.9%
|
|
Privium Fund Management B.V.
|
Jul 30, 2025 Q2 2025 |
197,458
shares
|
$1.36 Million
0.16% of portfolio
|
Q2 2025
Added 50.73%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
192,239
shares
|
$1.33 Million
0.0% of portfolio
|
Q2 2025
Reduced 41.96%
|
|
Jane Street Group, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
190,373
shares
|
$1.32 Million
0.0% of portfolio
|
Q2 2025
Added 35.13%
|
|
Royal Bank Of Canada
Toronto, A6 |
Aug 14, 2025 Q2 2025 |
172,728
shares
|
$1.19 Million
0.0% of portfolio
|
Q2 2025
Added 37045.81%
|
|
Perigon Wealth Management, LLC
San Francisco, CA |
Jul 15, 2025 Q2 2025 |
146,133
shares
|
$1.01 Million
0.01% of portfolio
|
Q4 2024
Reduced 0.03%
|
|
Bank Of New York Mellon Corp
New York, NY |
Aug 05, 2025 Q2 2025 |
141,100
shares
|
$975,001
0.0% of portfolio
|
Q2 2025
Added 4.64%
|
|
Invesco Ltd.
Atlanta, GA |
Aug 13, 2025 Q2 2025 |
140,325
shares
|
$969,645
0.0% of portfolio
|
Q2 2025
Added 19.15%
|
|
Man Group PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
134,932
shares
|
$932,380
0.0% of portfolio
|
Q2 2025
Added 159.72%
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Aug 14, 2025 Q2 2025 |
124,799
shares
|
$862,361
0.0% of portfolio
|
Q2 2025
Added 76.47%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
123,468
shares
|
$853,163
0.0% of portfolio
|
Q2 2024
Added 13.53%
|
|
Gsa Capital Partners LLP
London, X0 |
Jul 22, 2025 Q2 2025 |
117,719
shares
|
$813,438
0.03% of portfolio
|
Q2 2025
New holding
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
116,553
shares
|
$805,381
0.0% of portfolio
|
Q2 2025
Added 496.09%
|
|
Redmile Group, LLC
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
112,168
shares
|
$775,080
0.05% of portfolio
|
Q2 2025
Reduced 88.75%
|
|
Barclays PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
111,779
shares
|
$772,392
0.0% of portfolio
|
Q2 2025
Added 15.19%
|
|
Nuveen, LLC
Charlotte, NC |
Aug 12, 2025 Q2 2025 |
100,705
shares
|
$695,871
0.0% of portfolio
|
Q2 2025
Reduced 33.0%
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
96,519
shares
|
$666,946
0.0% of portfolio
|
Q2 2025
Reduced 59.18%
|
|
Xtx Topco LTD
London, X0 |
Aug 12, 2025 Q2 2025 |
78,580
shares
|
$542,987
0.01% of portfolio
|
Q2 2025
New holding
|
|
Rhumbline Advisers
Boston, MA |
Aug 12, 2025 Q2 2025 |
65,958
shares
|
$455,769
0.0% of portfolio
|
Q2 2025
Reduced 6.84%
|
|
Alliancebernstein L.P.
New York, NY |
Aug 14, 2025 Q2 2025 |
65,290
shares
|
$451,153
0.0% of portfolio
|
Q2 2025
Added 16.86%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Aug 12, 2025 Q2 2025 |
55,937
shares
|
$386,524
0.0% of portfolio
|
Q2 2025
Reduced 24.98%
|
|
Norges Bank
Oslo, Q8 |
Aug 13, 2025 Q2 2025 |
54,219
shares
|
$374,653
0.0% of portfolio
|
Q2 2025
New holding
|
|
Squarepoint Ops LLC
New York, NY |
Aug 27, 2025 Q2 2025 |
52,879
shares
|
$365,393
0.0% of portfolio
|
Q2 2025
New holding
|
|
Hsbc Holdings PLC
London, X0 |
Aug 13, 2025 Q2 2025 |
51,170
shares
|
$353,584
0.0% of portfolio
|
Q2 2025
Reduced 1.92%
|